Travere Therapeutics, Inc. (TVTX)
$65.49-$2.03 (-3.01%) Today
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 7 | 24,500 | $1.36M |
| Option exercise | 8 | 49,000 | |
| Bona-fide gift | 1 | 468 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
69 Form 4 filings on record, the earliest from Oct 4, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Gary A. Lyons - Director | Option exercise | Common Stock | 5,000 | $17.44 | $87K | |
| Gary A. Lyons - Director | Open-market sale | Common Stock | 1,900 | $62.53 | $119K | |
| Gary A. Lyons - Director | Open-market sale | Common Stock | 2,600 | $63.50 | $165K | |
| Gary A. Lyons - Director | Open-market sale | Common Stock | 500 | $64.16 | $32K | |
| Gary A. Lyons - Director | Option exercise | Common Stock | 5,000 | $17.44 | $87K | |
| Gary A. Lyons - Director | Open-market sale | Common Stock | 4,100 | $63.27 | $259K | |
| Gary A. Lyons - Director | Open-market sale | Common Stock | 900 | $63.86 | $57K | |
| Gary A. Lyons - Director | Option exercise | Stock option (right to buy) | 5,000 | $0.00 | - | |
| Gary A. Lyons - Director | Option exercise | Stock option (right to buy) | 5,000 | $0.00 | - | |
 Jula Inrig - Officer | Gift | Common Stock | 468 | $0.00 | - | |
| Timothy Coughlin | Option exercise | Common Stock | 10,000 | $26.52 | $265K | |
| Timothy Coughlin | Open-market sale | Common Stock | 10,000 | $50.07 | $501K | |
| Timothy Coughlin | Option exercise | Stock Option (Right to Buy) | 10,000 | $0.00 | - | |
| Roy D. Baynes | Option exercise | Common Stock | 4,500 | $21.38 | $96K | |
| Roy D. Baynes | Open-market sale | Common Stock | 4,500 | $50.00 | $225K | |
| Roy D. Baynes | Option exercise | Stock option (right to buy) | 4,500 | $0.00 | - | |
| Brinkley Ruth Williams | Grant or award | Common Stock | 4,000 | $0.00 | - | |
| Brinkley Ruth Williams | Grant or award | Stock option (right to buy) | 12,000 | $0.00 | - | |
| Ron Squarer | Grant or award | Common Stock | 4,000 | $0.00 | - | |
| Ron Squarer | Grant or award | Stock option (right to buy) | 12,000 | $0.00 | - | |
 Sandra Poole | Grant or award | Common Stock | 4,000 | $0.00 | - | |
| Sandra Poole | Grant or award | Stock option (right to buy) | 12,000 | $0.00 | - | |
| John A. Orwin | Grant or award | Common Stock | 4,000 | $0.00 | - | |
| John A. Orwin | Grant or award | Stock option (right to buy) | 12,000 | $0.00 | - | |
| Jeffrey A. Meckler | Grant or award | Common Stock | 4,000 | $0.00 | - | |
| Jeffrey A. Meckler | Grant or award | Stock option (right to buy) | 12,000 | $0.00 | - | |
| Gary A. Lyons | Grant or award | Common Stock | 4,000 | $0.00 | - | |
| Gary A. Lyons | Grant or award | Stock option (right to buy) | 12,000 | $0.00 | - | |
| Timothy Coughlin | Grant or award | Common Stock | 4,000 | $0.00 | - | |
| Timothy Coughlin | Grant or award | Stock option (right to buy) | 12,000 | $0.00 | - | |
 Suzanne Louise Bruhn | Grant or award | Common Stock | 4,000 | $0.00 | - | |
| Suzanne Louise Bruhn | Grant or award | Stock option (right to buy) | 12,000 | $0.00 | - | |
| Roy D. Baynes | Grant or award | Common Stock | 4,000 | $0.00 | - | |
| Roy D. Baynes | Grant or award | Stock option (right to buy) | 12,000 | $0.00 | - | |
| Timothy Coughlin | Open-market sale | Common Stock | 3,250 | $43.49 | $141K | |
| Roy D. Baynes | Option exercise | Common Stock | 4,500 | $18.27 | $82K | |
| Roy D. Baynes | Open-market sale | Common Stock | 4,500 | $46.65 | $210K | |
| Roy D. Baynes | Option exercise | Stock option (right to buy) | 4,500 | $0.00 | - | |
| Jeffrey A. Meckler | Option exercise | Common Stock | 8,000 | $16.33 | $131K | |
| Jeffrey A. Meckler | Open-market sale | Common Stock | 8,000 | $45.00 | $360K | |
| Jeffrey A. Meckler | Option exercise | Stock option (right to buy) | 8,000 | $0.00 | - | |
| William E. Rote - Officer | Option exercise | Common Stock | 4,250 | $0.00 | - | |
| William E. Rote - Officer | Open-market sale | Common Stock | 2,763 | $43.95 | $121K | |
| William E. Rote - Officer | Grant or award | Performance-based restricted stock units | 8,500 | $0.00 | - | |
| William E. Rote - Officer | Option exercise | Performance-based restricted stock units | 4,250 | $0.00 | - | |
 Elizabeth E. Reed - Officer | Option exercise | Common Stock | 20,000 | $17.96 | $359K | |
| Elizabeth E. Reed - Officer | Open-market sale | Common Stock | 20,000 | $45.00 | $900K | |
| Elizabeth E. Reed - Officer | Option exercise | Common Stock | 4,250 | $0.00 | - | |
| Elizabeth E. Reed - Officer | Open-market sale | Common Stock | 2,174 | $46.65 | $101K | |
| Elizabeth E. Reed - Officer | Open-market sale | Common Stock | 2,076 | $43.95 | $91K | |
| Elizabeth E. Reed - Officer | Option exercise | Employee stock option (right to buy) | 20,000 | $0.00 | - | |
| Elizabeth E. Reed - Officer | Grant or award | Performance-based restricted stock units | 8,500 | $0.00 | - | |
| Elizabeth E. Reed - Officer | Option exercise | Performance-based restricted stock units | 4,250 | $0.00 | - | |
| Jula Inrig - Officer | Option exercise | Common Stock | 20,000 | $22.40 | $448K | |
| Jula Inrig - Officer | Open-market sale | Common Stock | 20,000 | $45.00 | $900K | |
| Jula Inrig - Officer | Option exercise | Common Stock | 4,250 | $0.00 | - | |
| Jula Inrig - Officer | Open-market sale | Common Stock | 2,174 | $46.65 | $101K | |
| Jula Inrig - Officer | Open-market sale | Common Stock | 311 | $43.95 | $14K | |
| Jula Inrig - Officer | Option exercise | Employee stock option (right to buy) | 20,000 | $0.00 | - | |
| Jula Inrig - Officer | Grant or award | Performance-based restricted stock units | 8,500 | $0.00 | - | |
| Jula Inrig - Officer | Option exercise | Performance-based restricted stock units | 4,250 | $0.00 | - | |
 Peter Heerma - Officer | Option exercise | Common Stock | 4,250 | $0.00 | - | |
| Peter Heerma - Officer | Open-market sale | Common Stock | 2,174 | $46.65 | $101K | |
| Peter Heerma - Officer | Grant or award | Performance-based restricted stock units | 8,500 | $0.00 | - | |
| Peter Heerma - Officer | Option exercise | Performance-based restricted stock units | 4,250 | $0.00 | - | |
| Eric M. Dube - Officer | Option exercise | Common Stock | 22,500 | $0.00 | - | |
| Eric M. Dube - Officer | Open-market sale | Common Stock | 22,500 | $43.95 | $989K | |
| Eric M. Dube - Officer | Grant or award | Performance-based restricted stock units | 45,000 | $0.00 | - | |
| Eric M. Dube - Officer | Option exercise | Performance-based restricted stock units | 22,500 | $0.00 | - | |
| Christopher R. Cline - Officer | Option exercise | Common Stock | 4,250 | $0.00 | - | |
| Christopher R. Cline - Officer | Open-market sale | Common Stock | 2,181 | $46.65 | $102K | |
| Christopher R. Cline - Officer | Open-market sale | Common Stock | 310 | $43.95 | $14K | |
| Christopher R. Cline - Officer | Grant or award | Performance-based restricted stock units | 8,500 | $0.00 | - | |
| Christopher R. Cline - Officer | Option exercise | Performance-based restricted stock units | 4,250 | $0.00 | - | |
| Roy D. Baynes | Option exercise | Common Stock | 9,750 | $6.82 | $66K | |
| Roy D. Baynes | Open-market sale | Common Stock | 9,750 | $44.22 | $431K | |
| Roy D. Baynes | Option exercise | Stock option (right to buy) | 9,750 | $0.00 | - | |
| William E. Rote - Officer | Open-market sale | Common Stock | 9,100 | $39.09 | $356K | |
| Gary A. Lyons | Option exercise | Common Stock | 8,000 | $16.33 | $131K | |
| Gary A. Lyons | Open-market sale | Common Stock | 8,000 | $41.07 | $329K | |
| Gary A. Lyons | Option exercise | Stock option (right to buy) | 8,000 | $0.00 | - | |
| Roy D. Baynes | Option exercise | Common Stock | 8,000 | $17.94 | $144K | |
| Roy D. Baynes | Option exercise | Common Stock | 9,000 | $15.43 | $139K | |
| Roy D. Baynes | Option exercise | Common Stock | 4,500 | $18.27 | $82K | |
| Roy D. Baynes | Option exercise | Common Stock | 4,500 | $21.38 | $96K | |
| Roy D. Baynes | Option exercise | Common Stock | 6,750 | $17.11 | $115K | |
| Roy D. Baynes | Open-market sale | Common Stock | 26,000 | $41.07 | $1.07M | |
| Roy D. Baynes | Open-market sale | Common Stock | 6,750 | $42.12 | $284K | |
| Roy D. Baynes | Option exercise | Stock option (right to buy) | 8,000 | $0.00 | - | |
| Roy D. Baynes | Option exercise | Stock option (right to buy) | 9,000 | $0.00 | - | |
| Roy D. Baynes | Option exercise | Stock option (right to buy) | 4,500 | $0.00 | - | |
| Roy D. Baynes | Option exercise | Stock option (right to buy) | 4,500 | $0.00 | - | |
| Roy D. Baynes | Option exercise | Stock option (right to buy) | 6,750 | $0.00 | - | |
| Sandra Calvin - Officer | Option exercise | Common Stock | 2,500 | $22.40 | $56K | |
| Sandra Calvin - Officer | Option exercise | Common Stock | 6,250 | $8.93 | $56K | |
| Sandra Calvin - Officer | Option exercise | Common Stock | 6,500 | $20.46 | $133K | |
| Sandra Calvin - Officer | Open-market sale | Common Stock | 21,977 | $41.07 | $903K | |
| Sandra Calvin - Officer | Option exercise | Employee stock option (right to buy) | 2,500 | $0.00 | - | |
| Sandra Calvin - Officer | Option exercise | Employee stock option (right to buy) | 6,250 | $0.00 | - | |
| Sandra Calvin - Officer | Option exercise | Employee stock option (right to buy) | 6,500 | $0.00 | - | |
| Peter Heerma - Officer | Grant or award | Common Stock | 14,000 | $0.00 | - | |
| Peter Heerma - Officer | Open-market sale | Common Stock | 7,215 | $41.93 | $303K | |
| William E. Rote - Officer | Grant or award | Common Stock | 14,000 | $0.00 | - | |
| Eric M. Dube - Officer | Grant or award | Common Stock | 64,000 | $0.00 | - | |
| Eric M. Dube - Officer | Open-market sale | Common Stock | 56,815 | $41.01 | $2.33M | |
| Eric M. Dube - Officer | Open-market sale | Common Stock | 7,165 | $41.75 | $299K | |
| Eric M. Dube - Officer | Open-market sale | Common Stock | 20 | $42.66 | $853 |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| GARY LYONS | Director | 5,000 | $318K | View on EDGAR | |
| GARY A LYONS | Director | 5,000 | $311K | View on EDGAR | |
| - | - | - | - | View on EDGAR |
Travere Therapeutics, Inc. (TVTX) had 4 insider filings in the last 90 days, with the most recent on 2026-08-19. The full record for TVTX runs to 69 Form 4 filings, the earliest from 2024-10-04. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of TVTX were filed in the last 90 days.
7 insider sales of TVTX were filed in the last 90 days, totaling $1.36M.
This page tracks TVTX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add TVTX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
